By Benjamin Chiou
Date: Tuesday 22 Jul 2025
(Sharecast News) - French pharma giant Sanofi announced on Tuesday that it is to purchase London-based respiratory virus vaccine developer Vicebio for up to $1.6bn.
No recent information was found.
Currency | Euro |
Share Price | 81.25 |
Change Today | 0.48 |
% Change | 0.60 % |
52 Week High | 109.62 |
52 Week Low | 78.84 |
Volume | 124,567 |
Shares Issued | 1,256.00m |
Market Cap | 102,051m |
Beta | 0.76 |
Strong Buy | 13 |
Buy | 7 |
Neutral | 6 |
Sell | 0 |
Strong Sell | 1 |
Total | 27 |
Time | Volume / Share Price |
09:44 | 1 @ 81.25 |
09:44 | 3 @ 81.25 |
09:44 | 5 @ 81.23 |
09:44 | 98 @ 81.21 |
09:44 | 102 @ 81.21 |
You are here: research